Skip to content
LCC in Italian: Resectable EGFR-mutant NSCLC episode artwork

May 8, 2026 49 min

LCC in Italian: Resectable EGFR-mutant NSCLC

from Lung Cancer Considered Hosted by IASLC

As part of IASLC’s ongoing series of podcasts in world languages, Dr. Alfredo Addeo moderates a Virtual Tumor Board discussion with Dr. Andrea Fillipi and Dr. Piergiorgio Solli. The tumor board focuses on the management of resectable EGFR-mutant NSCLC. Host: • Alfredo Addeo, MD Head of Oncology Service University Hospital Geneva Guests: Andrea R. Filippi, MD Head of Radiation Oncology, Fondazione Istituto Nazionale dei Tumori, Milan Associate Professor, Radiation Therapy Department of Oncology, University of Milan Piergiorgio Solli, MD, PhD Head of Thoracic Surgery IRCCS Fondazione Istituto Nazionale dei Tumori, Milan

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

LCC in Italian: Resectable EGFR-mutant NSCLC

0:00 49:35

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Lung Cancer Considered?

This episode is 49 minutes long.

When was this Lung Cancer Considered episode published?

This episode was published on May 8, 2026.

Can I download this Lung Cancer Considered episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.